HIV and co-infections refer to the simultaneous presence of HIV and other infectious diseases such as tuberculosis (TB), hepatitis B and C, or various opportunistic infections that weaken the immune system further. These co-infections accelerate disease progression, complicate treatment, and increase mortality risks. Managing them requires integrated care models that combine antiretroviral therapy (ART) with screening, vaccination, and treatment for secondary infections. Global health programs increasingly emphasize early detection and comprehensive management of co-infections to improve patient outcomes and reduce transmission.
Market Analysis: In 2025, the global market for HIV and co-infection diagnostics and therapeutics is valued at around USD 42.5 billion, supported by rising demand for combination therapies, advanced diagnostic platforms, and preventive vaccines. The market is projected to grow to approximately USD 65.1 billion by 2030, at a CAGR of 8.9%, driven by government funding, NGO initiatives, and biopharmaceutical innovation. High-burden regions such as Sub-Saharan Africa and South Asia remain the largest demand centers, while North America and Europe lead in advanced drug development and precision medicine adoption.
Share this page on your timeline
ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Antiviral Drug Resistance Catheter-Associated Urinary Tract Infection Emerging Infectious Diseases Hospital-Acquired Infections HAIs Maternal-Fetal Infections Next-Generation Antibiotics Pediatric Infectious Diseases Sepsis Diagnosis and Care Zoonotic Diseases Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Lower Respiratory and Pediatric IDs Genomics and Infectious disease Special Session on COVID-19 Vaccines and Immunizations Antibiotic Sensitivity Testing Blood-Borne Disease Contagious Disease Encephalitis Global Pandemic Preparedness Influenza Surveillance Systems Microbiome and Immunity Occupational Safety and Health OSH Point-of-Care Testing POCT Travel-Related Infections Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Oral and Maxillofacial Infections Prevention and Control Public Health and Epidemiology Artificial Intelligence in ID Climate Change and Infections Gastroenteritis HIV and Co-Infections Malaria Elimination Strategies Neglected Tropical Diseases NTDs One Health Approach Rapid Diagnostic Innovations Tuberculosis Drug Resistance
Tags
Contagious Diseases Conferences
Infectious Disease Conferences 2026 Asia
Infection Conferences 2026
Infection Control Conferences
Infectious Diseases Conferences
Entomology Conferences
Bacteriology Conferences
Virology Conferences
Influenza Conferences
Vector-Borne Diseases Conferences
Parasitology Conferences
Infectious Disease Conferences
Infection Conferences 2027
Infection Conferences 2026 USA
Mycology Conferences